Levamisole compared to mebendazole in the treatment of Ancylostoma duodenale in Egypt
| Autor: | M.E. Kilpatrick, B. Trabolsi, Zoheir Farid |
|---|---|
| Rok vydání: | 1981 |
| Předmět: |
medicine.medical_specialty
ANCYLOSTOMATOIDEA Mebendazole Gastroenterology Ancylostomiasis Internal medicine parasitic diseases medicine Helminths Humans Intestinal Diseases Parasitic Ascariasis biology business.industry Ascaris Public Health Environmental and Occupational Health General Medicine Levamisole biology.organism_classification Regimen Infectious Diseases Ancylostoma duodenale Parasitology Benzimidazoles Egypt Ascaris lumbricoides business medicine.drug |
| Zdroj: | Transactions of the Royal Society of Tropical Medicine and Hygiene. 75(4) |
| ISSN: | 0035-9203 |
| Popis: | Ancylostoma duodenale in 74 patients and Ascaris lumbricoides in 41 were treated with a single 150 mg dose of levamisole, a single 300 mg dose of mebendazole or the standard three-day regimen of 200 mg mebendazole daily. Levamisole cured all of the 25 hookworm patients and all of the seven Ascaris carriers to whom it was given and is recommended as the drug of choice in Egypt. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|